Pharma Groups Urge CMS Not To Limit Drug Price Calculation
Five pharmaceutical industry groups asked the Centers for Medicare and Medicaid Services on April 2 not to proceed with a proposal to limit the sales figures that drugmakers can use to...To view the full article, register now.
Already a subscriber? Click here to view full article